Molecular Imaging: Page 9

Shine Technologies, Modawina Medical sign UAE distribution deal

By AuntMinnie.com staff writers

Shine Technologies has signed an agreement with Modawina Medical Company to distribute Shine’s lutetium-177 isotope in the UAE.

April 22, 2025

Atom Nuclear Lab 400

Combined PET scans predict the progression of Alzheimer’s disease

Combining information from amyloid PET and FDG-PET scans can predict progression from mild cognitive impairment to Alzheimer's.

April 21, 2025

Ad Pet Fdg Thumbnail

PET scans predict outcomes for patients undergoing CAR T-cell therapy

PET scans performed at one or three months after patients with large B-cell lymphoma begin CAR T-cell therapy can indicate whether they are responding to the treatment.

April 18, 2025

Pet Scan Patient

New theranostics PET tracer shows promise

A new gallium-68 (Ga-68) PET/CT radiotracer appears superior over F-18 FDG for detecting bone metastases.

April 17, 2025

Images of a 69-year-old man diagnosed with prostate cancer who had a history of endocrine therapy for two years. (a) The maximum intensity projection (MIP) image of F-18 FDG showed moderate radiotracer uptake in a thoracic vertebra. (e) The MIP image of Ga-68 DOTA-IBA demonstrated more lesions in the cervical vertebra and pelvis. (b) An osteoblastic lesion in the C3 vertebra right attachment (curved arrows) was negative on F-18 FDG (SUVmax = 2.0) and positive on Ga-68 DOTA-IBA (SUVmax = 8.7). (c) Another osteoblastic lesion in the T10 vertebra left side (arrowheads) was both positive on F-18 FDG (SUVmax = 5.2) and positive on Ga-68 DOTA-IBA (SUVmax = 35.0). (d) Osteoblastic lesions in bilateral ilium (dotted arrows and arrows) were negative on F-18 FDG (left: SUVmax = 1.4, right: SUVmax = 1.6) and positive on Ga-68 DOTA-IBA (left: SUVmax = 7.6, right: SUVmax = 8.7). Follow-up imaging three months later confirmed the presence of these bone metastases. Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of Scientific Reports.

PET/CT detects vasculitis following COVID-19 vaccination

A whole-body F-18 FDG-PET/CT scan was key in identifying medium-vessel vasculitis in a patient following a Moderna COVID-19 vaccination.

April 11, 2025

Covid 19 Vax Thumbnail

PET links depressive symptoms to Alzheimer’s brain pathology

Researchers have reported that worsening depression in older adults is related to higher levels of Alzheimer’s pathology.

April 10, 2025

IMV: PET procedure volumes continue strong growth trend

By Davin Korstjens

Overall PET procedure volumes increased by 12.2% in 2024, according to the IMV 2025 PET Market Summary Report.

April 10, 2025

Having a father with Alzheimer's could mean higher risk of the disease

By Kate Madden Yee

Having a father with Alzheimer's may be tied to a greater spread of the tau protein in the brain, researchers have reported.

April 9, 2025

PET reveals brain’s responses to music

PET has provided the first neuroimaging evidence that music affects the brain’s opioid receptor system.

April 7, 2025

2025 04 07 Pet Music Thumbnail

China limits exports of rare earth elements, targets CT x-ray tubes

By Erik L. Ridley

China's Ministry of Commerce has announced export controls for several rare earth elements and launched investigations of imported CT x-ray tubes.

April 4, 2025

SPECT/CT measure validated for diagnosing ATTR

A research team in Finland has validated the accuracy of a SPECT/CT measure for diagnosing transthyretin amyloidosis.

April 4, 2025

CAC score of 0 indicate low heart event risk, even in older people

By Kate Madden Yee

PET/CT imaging indicates that a coronary artery calcium (CAC) score of 0 is an accurate indicator of low coronary heart event risk even as a person ages, investigators have reported.

March 29, 2025

Page 9 of 610